PTX:ASX
Prescient Therapeutics Ltd
A$0.066
0.00%
(0.00) 1D
Oct 2, 4:00:00 PM GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
71.18M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
71.18M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
RealClearMarkets
·
4 hours ago
Here Are the Corporations Joining S&P 500
BigGo Finance
·
14 hours ago
Dow extends gains, rises 250 points to 51,176 as jobs report cools rate-hike bets
U.S. Global Investors
·
15 hours ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
StoneX
·
18 hours ago
Dow Jones Slide Shows What Rate Hike Bets Mean for Stocks
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com